K-numberK251831
Device nameBio-Medicus Life Support Catheter and Introducer
ApplicantMedtronic, Inc.
Product codeQHW
Device classClass II
Decision dateJan 15, 2026
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Bio-Medicus Life Support Catheter and Introducer is a single-lumen catheter system used to drain or reinfuse blood during extracorporeal support procedures including cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), and extracorporeal life support (ECLS). The introducer facilitates proper insertion and placement of the catheter within blood vessels. It is intended for use in adult and pediatric patients, with CPB applications limited to 6 hours and ECMO/ECLS for acute respiratory or cardiopulmonary failure when other treatments have failed.

Technological characteristics

The device maintains the same intended use, operating principle, design, material types, packaging, sterilization methods, and shelf life as the predicate. Design modifications include catheter body material formulation change, hemostasis cap material change, removal of encapsulated urethane layer, modification of catheter body reinforcements from radial slots to holes, introducer taper angle adjustment to 6 degrees (mini catheters only), and barbed connector variants utilizing reference device components.

Test standards cited

ISO 18193:2021 (Cardiovascular Implants and Artificial Organs — Cannulae for Extracorporeal Circulation), ISO 10993-1:2018 (Biological evaluation of medical devices), and FDA guidance on Use of International Standard ISO 10993-1 dated September 8, 2023.

Substantial equivalence argument

The modified device is substantially equivalent because it shares identical intended use, operating principle, device design, material types, packaging, sterilization, and shelf life with the predicate device (K201057, K201100). All component modifications underwent risk-based testing including functional and biocompatibility assessments, demonstrating that changes do not affect the fundamental safety and effectiveness profile. Performance testing confirms compliance with ISO 18193:2021 and equivalent technological characteristics, biocompatibility, sterility, and in vivo performance over 7 days of use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →